MedTrace Logo

The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC

NCT06042842 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2023-10-04

No results posted yet for this study

Summary

1. To evaluate the clinical utility of plasma circRNAs (hsa\_circ\_0004001) as a non invasive diagnostic biomarker for HCC patients and to differentiate between malignant and nonmalignant hepatic disorders.
2. To study the relation of circRNAs (hsa\_circ\_0004001) to HCC staging.
3. To compare between circRNAs (hsa\_circ\_0004001) and the routine marker (AFP) as biomarkers for HCC diagnosis.

Conditions

  • Hepatic Cell Carcinoma

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2024-12-31
Completion
2025-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06042842 on ClinicalTrials.gov